Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.
about
MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerEmerging technologies for studying DNA methylation for the molecular diagnosis of cancerMultiple network algorithm for epigenetic modules via the integration of genome-wide DNA methylation and gene expression data.Methylome-wide association study of whole blood DNA in the Norfolk Island isolate identifies robust loci associated with age.RNA-Seq based genome-wide analysis reveals loss of inter-chromosomal regulation in breast cancer.DFNA5 promoter methylation a marker for breast tumorigenesisDNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal CarcinomaEpigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes.Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscopeDNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell lines.The integrative epigenomic-transcriptomic landscape of ER positive breast cancer.A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness.Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy womenEpigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.Isoforms, structures, and functions of versatile spectraplakin MACF1.Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patientExcerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway.Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 modelIdentification of Genetic and Epigenetic Variants Associated with Breast Cancer Prognosis by Integrative Bioinformatics Analysis.Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.Concordance of DNA methylation profiles between breast core biopsy and surgical excision specimens containing ductal carcinoma in situ (DCIS).Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.Glycan-related gene expression signatures in breast cancer subtypes; relation to survival.Deconvolution of DNA methylation identifies differentially methylated gene regions on 1p36 across breast cancer subtypes.Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age.Genome-wide DNA Methylation Associations with Spontaneous Preterm Birth in US Blacks: Findings in Maternal and Cord Blood Samples.DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis.Cancer genomics just got personal.Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer.DNA methylation at enhancers identifies distinct breast cancer lineages.Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.Breast Cancers Activate Stromal Fibroblast-Induced Suppression of Progenitors in Adjacent Normal Tissue.DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk.Epigenetic alterations to Polycomb targets precede malignant transition in a mouse model of breast cancer.Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns.
P2860
Q26775086-4087682F-765B-420F-A3F8-1C7BE4847D2AQ28087759-B4B66CA0-B81E-4790-91F4-E625D383D833Q31157831-717DF019-403C-4A4A-B2B4-3306F6020B0DQ33563583-8E6AD58C-93F9-443B-A4B8-05DBD21888E0Q33687763-D6D203DF-1BAD-4301-9635-A5637D91AD8AQ33761973-94754661-7C84-4231-8FAF-8A1DF1139597Q33893710-0014D743-3327-43F8-9FB2-D2B1238A0872Q33911898-CB5276A6-4B3D-4A47-87C9-18B3E64C851CQ34558559-0ABD5A2F-D2D0-4F57-B1F3-4C6E484FD4E8Q35331865-7563FAF0-2A73-42D0-8D29-1B4045EE2071Q35888926-E869E12F-758F-4151-8BF2-9089B0C29664Q35897588-20D48D75-03C9-482B-881A-FC37E0E735D1Q36268784-91D80869-C392-491D-9E84-FEAAFD103A4AQ36357800-F44F5D68-4951-4027-862D-3CA47921C530Q36545127-4555A362-1DC8-4F60-A914-2B22EE1D7680Q36833450-B4845CBD-1890-4A7D-BA7E-45CEF1A96AEFQ36957014-3F398C45-59C2-4760-AE9C-5010C6BEBE65Q37021898-AD9AE921-AA6D-49FC-A3DE-BD4AA8F0CB55Q37317308-FA19EF57-A503-4F92-A7FF-8A7CB9CB6F8CQ37349280-C4969353-17C4-43C9-A11B-F5D60D8FDEC5Q37371138-86C6EAB8-9850-4839-BB42-92CA35DCD74AQ37577093-60FC8670-6192-47FB-A22A-6FC65FE13494Q37639092-D305C7DF-F6B5-47ED-8085-44F674BFA18CQ37702047-6691F627-1266-45D2-A09C-F397A9D4A13DQ38677455-70F1337F-FF70-4F13-914B-7AA2C69B470CQ38693071-2C33E7F5-F89E-4AEF-90C9-4CFCE2D2B609Q39042751-D65C540C-6590-4B0F-A095-F6B6F0555368Q40040077-AC88FE20-4B16-453C-A906-9149DF220C90Q40128723-A0DCB5C5-EBD9-4E71-8713-1BE44899948CQ40348183-51E9BE6C-B372-4241-B054-FDB95916A781Q41048773-FAEF2223-105F-495A-9B14-69D2144109D0Q41101024-496AF340-C4F3-4D10-9A5F-612C52D24EAFQ42027887-9DB79C53-5E22-4CF9-B0BD-36D49E211EC3Q42367899-9AD56B37-CA5B-4B9C-8FDC-FF2D30580B4DQ43700782-674F3116-41C4-4AFB-BE9B-9BA70C6F14FDQ46699535-DD277603-E3E0-450B-91E4-470E7163A0DCQ49220877-76DC5ACF-AF11-4659-ADB8-7764345A2D5BQ50040373-A55F7F8A-5604-4E2C-8149-202CF5BB351CQ52332848-BB53C16A-3553-4510-8B20-A41CBE4B1199Q52575440-35BBADA9-F201-4A14-81AD-DE78653C830A
P2860
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genome-wide DNA methylation pr ...... e transcription and prognosis.
@ast
Genome-wide DNA methylation pr ...... e transcription and prognosis.
@en
Genome-wide DNA methylation pr ...... e transcription and prognosis.
@nl
type
label
Genome-wide DNA methylation pr ...... e transcription and prognosis.
@ast
Genome-wide DNA methylation pr ...... e transcription and prognosis.
@en
Genome-wide DNA methylation pr ...... e transcription and prognosis.
@nl
prefLabel
Genome-wide DNA methylation pr ...... e transcription and prognosis.
@ast
Genome-wide DNA methylation pr ...... e transcription and prognosis.
@en
Genome-wide DNA methylation pr ...... e transcription and prognosis.
@nl
P2093
P2860
P50
P1433
P1476
Genome-wide DNA methylation pr ...... e transcription and prognosis.
@en
P2093
Arnoldo Frigessi
Brock C Christensen
Jovana Klajic
Kevin C Johnson
Margit Lh Riis
Nizar Touleimat
P2860
P356
10.1186/PREACCEPT-2333349012841587
P50
P577
2014-08-22T00:00:00Z
P6179
1064134515